Literature DB >> 15250095

["Anti-aging" from a cardiologist's view].

U Laufs1, M Böhm.   

Abstract

The bases of "anti-aging" therapy are smoking cessation, diet and physical activity. In addition, individuals can be identified, on the basis of their global vascular risk, who will benefit from pharmacotherapy to control blood pressure, lipids and platelet aggregation. From the cardiologist's perspective, there is at present no evidence indicating the use of vitamins, antioxidants or hormone therapy in cardiovascular prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250095     DOI: 10.1007/s00120-004-0575-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  18 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  [The global risk for cardiovascular disease. Who is a candidate for pharmacological prevention?].

Authors:  H Gohlke
Journal:  Z Kardiol       Date:  2004

3.  Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 4.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

5.  [Not Available].

Authors:  G Wiesner; J Grimm; E Bittner
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2002-05       Impact factor: 1.513

6.  Alcohol and mortality in middle-aged men from eastern France.

Authors:  S C Renaud; R Guéguen; J Schenker; A d'Houtaud
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

7.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

8.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).

Authors:  Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T Bruce Ferguson; Stephan D Fihn; Theodore D Fraker; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

9.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

10.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.